MedPath

Pericapsular Nerve Group Block for Total Hip Arthroplasty

Not Applicable
Completed
Conditions
Postoperative Pain
Hip Arthropathy
Interventions
Procedure: Pericapsular nerve group block with ropivacaine
Procedure: Pericapsular nerve group block with saline solution
Registration Number
NCT04295408
Lead Sponsor
University Tunis El Manar
Brief Summary

Controlling pain after hip replacement surgery improves comfort and partient satisfaction. Pain after hip replacement has traditionally been managed using systemic pain medications including acetaminophen and non-steroidal anti-inflammatory drugs. A recent Cochrane review demonstrated that compared to systemic analgesia alone, peripheral nerve blocks reduce postoperative pain with moderate-quality evidence. Pericapsular Nerve Group block is a new technique allowing local anesthetic diffusion to femoral, obturator and accessory obturator nerves and providing a good analgesic effect for hip fracture surgery. Investigators hypothesized that the PENG block could be an interesting alternative to systemic analgesiscs for pain control after total hip replacement.

Detailed Description

The aim of the study was to evaluate the efficacy of the PENG block for intra and postoperative pain control in total hip arthroplasty.

it was a monocentric, randomized, controlled and double blind study. Patients scheduled for primary THA with lateral approach under general anesthesia.

Premedication with IV midazolam 1 to 2 mg on arrival to operating theatre. general anesthesia was conducted using fentanyl, propofol and cisatracurium for induction and isoflurane for maintanance patients were randomized using a random table in two groups:

* PENG Block group (PG) who received 2 mg.kg-1Ropivacaine in 40 ml of saline.

* Placebo group (SG) who received 40 ml of saline.

Postoperative analgesia started before extubation of the patient, with:

* IV paracetamol 1g/6h in Day1 and oral paracetamol 1g/8h for 6 days.

* non steroidal anti inflammatory drugs with IM piroxicam 20 mg on day one (at the end of surgery) and oral diclofenac 50 mg/12h for 3 days.

* Morphine PCA for day 1 (24 H) and oral tramadol 50 mg/12h from day 2 to day 6.

Recruitment & Eligibility

Status
COMPLETED
Sex
All
Target Recruitment
60
Inclusion Criteria
  • primary THA with lateral approach under general anesthesia.
Exclusion Criteria
  • Hip fracture,
  • allergy to local anesthetics,
  • peripheral neuropathy,
  • creatinin clearance inferior to 30ml/min,
  • weight inferior to 50 Kg or superior to 100 Kg,
  • neurological disorder affecting the lower extremity, significant psychiatric conditions,
  • patients receiving corticosteroid therapy,
  • chronic consumption of opioids (>2 months).

Study & Design

Study Type
INTERVENTIONAL
Study Design
PARALLEL
Arm && Interventions
GroupInterventionDescription
Pericapsular nerve group blockPericapsular nerve group block with ropivacainePericapsular Nerve Group block with 2 mg.kg-1Ropivacaine in 40 ml of saline
PLACEBOPericapsular nerve group block with saline solutionPericapsular Nerve Group block with 40 ml saline
Primary Outcome Measures
NameTimeMethod
Total morphine consumptionday one

morphine consumption on mg

Secondary Outcome Measures
NameTimeMethod
Pain score after extubationup to 30 minutes

simplified numerical score (SNS) after extubation \[0=no pain , 10=worst pain\].

intraoperative opioid consumptionDay 0

total intraoperative fentanyl consumption on microg

postoperative pain scoreday one

simplified numerical score (SNS) \[0=no pain , 10=worst pain\].

Pain score during seating positionday one

simplified numerical score (SNS) during seating position \[0=no pain , 10=worst pain\].

Trial Locations

Locations (1)

Institut Kassab D'Orthopedie

🇹🇳

Tunis, Tunisia

© Copyright 2025. All Rights Reserved by MedPath